MWA CONSULTING, INC.
  • Home
  • About MWA
  • Consulting Services
  • Industry News
  • Resource Center
    • Webinars
    • Blogs
    • Podcasts
  • Consulting Opportunities
  • Contact Us
  • Privacy Policy
Select Page

FDA Announces Availability of Portal and draft Guidance on Reporting Amount of Listed Drugs and Biological Products

Oct 29, 2021

FDA has announced the new use of a NextGen Portal for reporting the annual amount of listed human and animal drugs and human biological products that an establishment manufactured, prepared, propagated, compounded, or processed (including repacking and relabeling) for...

Stay current with FDA regulatory news and compliance trends!

Follow MWA on LinkedIn:

Recent Posts

  • FDA’s Informed Consent Regulations for Clinical Investigations
  • Quality Systems, Part 2: Developing Effective CAPAs
  • FDA’s Published Guidance from CDER Program for the Recognition of Voluntary Consensus Standards Related to Pharmaceutical Quality
  • FDA Fiscal Year 2022 Report on the State of Pharmaceutical Quality
  • What is GxP in pharma?

Designed by Elegant Themes | Powered by WordPress